As of 3:59pm ET
| +0.0007 / +0.08%|
The 3 analysts offering 12-month price forecasts for Interpace Diagnostics Group Inc have a median target of 3.00, with a high estimate of 4.50 and a low estimate of 3.00. The median estimate represents a +229.71% increase from the last price of 0.91.
The current consensus among 3 polled investment analysts is to Buy stock in Interpace Diagnostics Group Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.